A Randomized, Double Masked, Active Controlled, Phase 3 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects With Neovascular Age-related Macular Degeneration (AMD)
A Randomized, Double Masked, Active Controlled, Phase 3 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects With Neovascular Age-related Macular Degeneration (AMD)
This study is a phase III, double-masked, randomized, study of the efficacy and safety of VEGF Trap-Eye in patients with neovascular age-related macular degeneration. Approximately 1200 patients will be randomized in Europe, Asia, Japan, Australia and South America.
Data of this trial ("VIEW 2") was pooled with data of a sister trial ("VIEW 1", NCT00509795), and an integrated analyses of the combined data was performed.
Inclusion Criteria:
Exclusion Criteria:
Cali, Cauca Department, Colombia
Ahemedabad - 4, Gujarat 380009, India
Wadala, Mumbai, Maharashtra 400031, India
Pondicherry, Tamil Nadu 600007, India
Kerala, 683572, India
Orissa, 751 024, India
Zrifin, Israel 70300, Israel
Kita, Kagawa-ken 761-0793, Japan
Chiyoda-ku, Tokyo 101-8309, Japan
Shinjuku-ku, Tokyo 160-8582, Japan
México D.F., 04030, Mexico
Warszaa, 02-005, Poland